A

Infusion therapies

Infusion therapies are usually used as a backup treatment for people who have had an inadequate response to, or are unable to tolerate, injectable therapies for RRMS, or who are experiencing a worsening form of RRMS.

Infusion therapy is delivered by a process called intravenous (IV) infusion, which means it is delivered directly to your bloodstream through a vein. There are 2 available infusion therapies. Both must be administered in a medical facility.

Both infusion therapies have a black box warning which you should discuss with your doctor.

Novantrone® (mitoxantrone for injection concentrate)
Tysabri® (natalizumab)

062235188/061271

A

Novantrone® is a registered trademark of Serono, Inc.
Tysabri® is a registered trademark of Elan Pharmaceuticals, Inc.